Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Latest
0.00%
↓ 100% vs avg
Percentile
P21
Within normal range
Average
56.90%
Historical baseline
PeriodValue
Q4 20250.00%
Q3 20250.00%
Q2 20250.00%
Q1 20250.00%
Q4 20240.00%
Q3 20240.00%
Q2 20240.00%
Q1 20240.00%
Q4 20230.00%
Q3 20230.00%
Q2 20230.00%
Q1 20230.00%
Q4 20220.00%
Q3 20220.00%
Q2 2022-100.00%
Q1 2022-93.65%
Q4 20211676.78%
Q3 2021170.37%
Q2 20210.00%
Q1 2021-100.00%
Q4 2020-44.50%
Q3 202013.44%
Q2 20200.00%
Q1 2020-100.00%
Q4 20190.00%